IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,000 | +46.2% | 49,876 | +70.9% | 0.00% | +100.0% |
| Q2 2022 | $13,000 | -43.5% | 29,179 | -37.1% | 0.00% | -50.0% |
| Q1 2022 | $23,000 | -94.1% | 46,368 | -85.7% | 0.00% | -94.7% |
| Q2 2021 | $390,000 | +104.2% | 325,330 | +120.9% | 0.04% | +171.4% |
| Q1 2021 | $191,000 | +377.5% | 147,252 | +568.2% | 0.01% | +250.0% |
| Q4 2019 | $40,000 | +21.2% | 22,038 | +84.8% | 0.00% | +100.0% |
| Q4 2018 | $33,000 | – | 11,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
| Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
| Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
| MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
| WADE G W & INC | 35,000 | $42,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
| BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |